Patients suffering from malignant brain tumors are burdened with a grim prognosis. The blood brain barrier is considered a primary obstacle in therapeutic drug delivery to the brain. Intra-arterial ...
Background and purpose Flow diverters (FDs) have become one of the primary treatments for intracranial aneurysms (IAs). However, their use in distal IA has been associated with higher complication ...
Neurointervention is a highly specialized area of medicine and, as such, neurointerventional research studies are often more challenging to conduct, require large, multicenter efforts and longer study ...
Background Middle meningeal artery embolization (MMAE) is a promising treatment for non-acute subdural hematoma (NASDH), but trial evidence is limited by heterogeneity and open label design bias. This ...
Background To monitor endovascular and surgical care quality, the US Agency of Healthcare Research and Quality (AHRQ) has established a “failure-to-rescue” safety metric - Patient Safety Indicator ...
Ehlers–Danlos syndrome (EDS) type IV is a collagen vascular disease with an autosomal dominant inheritance caused by COL3A1 mutation. Patients with EDS type IV can present with organ rupture, ...
Background Selective and superselective intra-arterial cerebral infusion (SIACI/SSIACI) delivers chemotherapy directly to tumor-supplying arteries, achieving high local drug levels with reduced ...
Objective To evaluate the efficacy and safety of the subclavian loop catheter technique for endovascular stenting of vertebral artery ostial stenosis (VAOS). Methods We retrospectively reviewed all ...
Background Delayed intraparenchymal hemorrhage (DIPH) is a severe complication after pipeline embolization device (PED) deployment for intracranial aneurysms (IAs). However, predictive models are ...
7 Central Institute for Diagnostic and Interventional Radiology Neuroradiology and Nuclear Medicine, Offenbach am Main, Germany 8 Institute for Diagnostic and Interventional Radiology and ...
Background Inflammation drives damage in acute ischemic stroke (AIS). Here, we map temporal and molecular mechanisms of immune-vascular response in patients with AIS treated with endovascular ...
Correspondence to Dr Matthew J Gounis, Department of Radiology Director, New England Center for Stroke Research University of Massachusetts, 55 Lake Ave N, SA-107R, Worcester, MA 01655, USA; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback